Approval · Notice of Compliance 1105 · 2000
ANZEMET: Notice of Compliance 1105
Issued June 16, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1105
- Date
- June 16, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiemetic (5-ht3 receptor antagonist)
Products in this notice
Medicinal ingredients
- DOLASETRON MESYLATE 20 MG per ML
- DOLASETRON MESYLATE 50 MG per TAB
- DOLASETRON MESYLATE 100 MG per TAB